DARE MEXC RealStocks
Own real DARE shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-14 19:31:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Dare Bioscience, Inc. (DARE) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0.65, with a market capitalization of $12.67M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.61 to $3.78. This page covers its latest market performance, valuation, price trends and company information.
$12.67M | |
$0.65 | |
$0.66 | |
$0.64 | |
$0.64 | |
63.02K | |
261.62K | |
-- | |
$3.78 | |
$0.61 | |
-- | |
-- |
Dare Bioscience, Inc. (DARE) last closed at $0.65 as of 2026-11-14 00:57:00, up 0.62% ($0.00) from the previous close of $0.64.
During the latest regular trading session, DARE traded between $0.64 and $0.66, with a volume of 63.02K shares. The closing price was near the middle and near the lower end of its 52-week range.
Over the past seven days, Dare Bioscience, Inc. (DARE) moved from $0.62 to $0.65, representing a gain of 3.37% ($0.02).
The stock traded between $0.61 and $0.72 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 96.50 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 1.1%
DARE is currently trading at $0.65, placing it 1.1% of the way from its 52-week low of $0.61 to its 52-week high of $3.78. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 24 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Dare Bioscience, Inc. (DARE) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to DARE, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between DARE shares and USD.
DARE Shares to USD
1.00 DARE shares = 0.645 USD
Calculations are estimates based on the latest available price and are for reference only.